About Fellow

Saha Institute of Nuclear Physics, Kolkata, India

1. Indian Institute of Science, Bangalore, India (March, 2014 to March 2016)
2. Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata (June, 2016 to present)

Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India

My scientific interest developed during my Masters and I decided to build my career in biomedical research. In the final year of my M.Sc., I spent two months at IIT, Kharagpur for my summer project and experienced the essence of how a research laboratory works. After my M.Sc., I joined Saha Institute of Nuclear Physics to work on Alzheimer’s disease, which is basically a neurodegenerative disorder of the elderly. During this period, I got basic training in Biochemistry, Molecular Biology and Cell Biology. My focus was on interaction proteomics and its implications in health and disease. At that time, I started to work closely with clinicians and realized the importance of collaboration between basic scientists and clinicians in doing translational research. After completion of my PhD, I moved to IISc. bangalore to work as a postdoctoral fellow in an Alzheimer’s disease project at Centre for Neuroscience.

In the final year of my PhD, I became interested in understanding the link between neurodegeneration and cancer. For that, I was exposed to a lot of cancer literatures and became more inclined towards translational research in cancer. At the same time, Tata Translational Cancer Research Centre was started to grow and I had a chance to interact with Prof. Vaskar Saha. I had several interactions with him and got motivated to work with Childhood leukemia especially Acute Lymphoblastic Leukemia (ALL). From June 2016, I started my scientific journey in the field of ALL research at TTCRC. Here, I can work closely with the clinician scientists and be enriched with respect to scientific quest and thinking. The motivation behind taking this topic of my research is the increased rate of relapse in ALL patients and the need for better risk-stratification for altered cost-effective treatment strategy as well as to identify key molecular players of childhood ALL. Throughout the different stages of ECF application process, I learnt many important aspects of how to write a good grant proposal. The India Alliance team was also very supportive throughout.